Project Grant HT94252510603
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
- The federal Project Grant award of $1,552,867.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The award supports advanced biomedical research focused on the early detection of endometrial carcinoma through cell enrichment and flow cytometry. The performance period runs from Sep 30, 2025 to Sep 29, 2028. As a leading federal research institution, Johns Hopkins has a demonstrated track record of...
- The federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award period runs from July 1, 2025 to June 30, 2028 and aims to advance biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- This federal Project Grant award of $360,413.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University focused on early hepatic dissemination of pancreatic cancer. The research aims to evaluate the efficacy of systemic chemotherapy-enhanced alpha-particle radiotherapy as a treatment approach. The award has a performance period from November 1, 2024 to October 31, 2027. As a leading academic...
- This federal Project Grant award of $388,194 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research led by The Johns Hopkins University to investigate the aging microenvironment as a driver of pancreatic cancer metastasis. The 3-year project, beginning on July 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research on critical health challenges....
- This federal Project Grant award of $1,228,021.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting The Johns Hopkins University in advancing clinical research in ovarian cancer. The grant, awarded on June 1, 2024, will fund the university's efforts to conduct innovative scientific studies and clinical trials over a four-year performance period ending on May 31, 2028. This award enables Johns Hopkins to leverage its expertise...
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
- The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
- This $484,013 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of "PSMA-TARGETED MULTIPARAMETRIC ULTRASOUND" research at The Johns Hopkins University. The award period runs from August 1, 2024 to July 31, 2026. The project aims to advance biomedical research and innovative medical solutions relevant to military personnel and the broader public. As a leading research institution, The...
- This federal Project Grant award of $606,060.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to engineer receptors to promote effective infiltration of CAR T cells into bladder tumors. The award, which runs from July 15, 2025 to July 14, 2027, aims to develop innovative medical solutions that address critical health challenges relevant to military personnel and civilian populations. As a leading...